Ocular Biomarker Laboratory

Researcher

Research Overview

The Ocular Biomarker Laboratory is interested in ways in which we can utilise the unique attributes of the eye to inform us about cortical disease and drug development.

Staff

  • Dr Vickie Wong
  • Dr Jeremiah Lim (postdoc)
  • Dr Bao Nguyen (postdoc)
  • Darren Zhao (PhD student)
  • Jonathan Lay (Masters student)
  • Katie Tran (honours student)
  • Amy Wang (honours student)
  • Ronald Wu (honours student)

Collaborators

Industry:

  • Biogen Pty Ltd, USA
  • AstraZeneca Pty Ltd, USA
  • Thea Laboratories; New Zealand and France
  • Pfizer Pty Ltd, USA

Academia:

  • A/Prof Bang Bui, Department of Optometry and Vision Sciences, University of Melbourne
  • Prof Algis Vingrys, Department of Optometry and Vision Sciences, University of Melbourne
  • Prof John Morrison, Oregan Health and Science University, USA
  • Dr Qiao-Xin Li, Florey Neuroscience Institute, Melbourne Brain Centre, Australia
  • A/Prof David Finkelstein, Florey Neuroscience Institute, Melbourne Brain Centre, Australia
  • A/Prof Mourad Tayebi,  Western Sydney University, Australia
  • Dr Emma Burrows, Florey Neuroscience Institute, Melbourne Brain Centre, Australia
  • A/Prof Paul Adlard, Florey Neuroscience Institute, Melbourne Brain Centre, Australia
  • Prof Kevin Barnham, Dr Vijaya Kenche, Florey Neuroscience Institute, Melbourne Brain Centre, Australia
  • Dr Tim Ryan from Florey Neurosciences Institute, Melbourne Brain Centre, Australia
  • Prof Andrew Sinclair, Deakin University, Australia

Funding

The Nguyen Ocular Biomarker Laboratory currently receives funding from:

  • ARC-Linkage with AstraZeneca and Biogen “Multimodal imaging of the eye provides “insight” into ageing”
  • Melbourne Neuroscience Institute Interdisciplinary Seed Fund. “The eye as a window to Parkinson’s disease”
  • Melbourne Research Fellowships (Career Interruptions) “Using the eye as a window into brain disease”

The laboratory has also received funding from Melbourne Research Grant Support Scheme (2016), Melbourne School of Health Sciences Seed funding(2015), Melbourne Neuroscience Institute Fellowship (2014), ARC-Linkage with Pfizer Global Research and Development (2010-2014), Research Collaboration Grant (2013), Kaye Merlin Brutton bequest (2011).